Epizyme, Inc. Uncategorized Contracts & Agreements

28 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Contingent Value Rights Agreement
Epizyme, Inc.
Biotechnology
DE
2022
Form of Support Agreement
Epizyme, Inc.
Biotechnology
2022
Second Amendment to the Companion Diagnostics Agreement dated November 16, 2015 between the Registrant and Eisai Co. Ltd. on the one side and Roche Molecular Systems, Inc. on the...
Epizyme, Inc.
Biotechnology
2022
First Amendment to the Companion Diagnostics Agreement dated October 23, 2013 between the Registrant and Eisai Co. Ltd. on the one side and Roche Molecular Systems, Inc. on the...
Epizyme, Inc.
Biotechnology
2022
Companion Diagnostics Agreement dated as of December 18, 2012 between the Registrant and Eisai Co., Ltd. on the one side and Roche Molecular Systems, Inc. on the other side
Epizyme, Inc.
Biotechnology
DE
2022
Description of Securities of the Registrant
Epizyme, Inc.
Biotechnology
2020
- 2 -
Epizyme, Inc.
Biotechnology
2016
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Epizyme, Inc.
Biotechnology
2016
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Epizyme, Inc.
Biotechnology
NY
2015
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Epizyme, Inc.
Biotechnology
2015
EPIZYME, INC. RESTRICTED STOCKUNIT AGREEMENT
Epizyme, Inc.
Biotechnology
DE
2015
- 2 -
Epizyme, Inc.
Biotechnology
2015
- 2 -
Epizyme, Inc.
Biotechnology
2014
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Epizyme, Inc.
Biotechnology
2014
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Epizyme, Inc.
Biotechnology
2014
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Epizyme, Inc.
Biotechnology
2014
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Epizyme, Inc.
Biotechnology
2013
Confidential Materials omitted and filed separately with the Securities andExchange Commission. Double asterisks denote omissions.
Epizyme, Inc.
Biotechnology
IL
2013
Confidential Materials omitted and filed separately with the Securities andExchange Commission. Double asterisks denote omissions.
Epizyme, Inc.
Biotechnology
WA
2013
Confidential Materials omitted and filed separately with the Securities andExchange Commission. Double asterisks denote omissions.
Epizyme, Inc.
Biotechnology
DE
2013
[Company Letterhead]
Epizyme, Inc.
Biotechnology
2013
[Company Letterhead]
Epizyme, Inc.
Biotechnology
2013
[Company Letterhead]
Epizyme, Inc.
Biotechnology
2013
[Company Letterhead]
Epizyme, Inc.
Biotechnology
2013
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Epizyme, Inc.
Biotechnology
2013
Confidential Materials omitted and filed separately with the Securities andExchange Commission. Double asterisks denote omissions.
Epizyme, Inc.
Biotechnology
IL
2013
Confidential Materials omitted and filed separately with the Securities andExchange Commission. Double asterisks denote omissions.
Epizyme, Inc.
Biotechnology
WA
2013
Confidential Materials omitted and filed separately with the Securities andExchange Commission. Double asterisks denote omissions.
Epizyme, Inc.
Biotechnology
DE
2013